NEUROFIBROMATOSIS-1 (NF1) MESSENGER-RNAS EXPRESSED IN THE CENTRAL-NERVOUS-SYSTEM ARE DIFFERENTIALLY SPLICED IN THE 5' PART OF THE GENE

被引:69
作者
DANGLOT, G [1 ]
REGNIER, V [1 ]
FAUVET, D [1 ]
VASSAL, G [1 ]
KUJAS, M [1 ]
BERNHEIM, A [1 ]
机构
[1] HOP LA PITIE SALPETRIERE,F-75013 PARIS,FRANCE
关键词
D O I
10.1093/hmg/4.5.915
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neurofibromatosis 1 gene seems to play essential roles at several different stages of life, During embryogenesis, it is involved in cardiac development while in the adult, neurofibromin (the corresponding protein) is mainly expressed in the nervous system, and therein, essentially in neurons, non-myelinating Schwann cells and oligodendrocytes, In addition, the NF1 gene is considered a tumor suppressor gene, since mutations have been associated with the occurrence of benign and malignant tumors in neural-crest-derived tissues, Using reverse transcription-polymerase chain reaction (RT-PCR) analyses with primers located in exons 7 and 13, we have identified evidence of alternative splicing in this region of the NF1 gene, Cloning and sequencing of cDNA allowed the characterization of an isoform bearing an extra 30 bp sequence between exons 9 and 10a, leading to the insertion of 10 amino acids between residues 420 and 421 of neurofibromin, The insertion is conserved in the mouse, Examination of the pattern of expression of this isoform demonstrated a high level of expression in the central nervous system and an absence of expression in all the other normal tissues tested including peripheral nervous tissues derived from the neural crest, Analysis of brain tumors indicated a reduced expression of the alternative exon in medulloblastomas and oligodendrogliomas. The results presented here are consistent with tissue-specific expression of this alternative exon which we propose to call exon 9br.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 29 条
  • [11] ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS
    DECLUE, JE
    PAPAGEORGE, AG
    FLETCHER, JA
    DIEHL, SR
    RATNER, N
    VASS, WC
    LOWY, DR
    [J]. CELL, 1992, 69 (02) : 265 - 273
  • [12] GUTMANN DH, 1993, HUM MOL GENET, V2, P989
  • [13] DIFFERENTIAL EXPRESSION AND TISSUE DISTRIBUTION OF TYPE-I AND TYPE-II NEUROFIBROMINS DURING MOUSE FETAL DEVELOPMENT
    HUYNH, DP
    NECHIPORUK, T
    PULST, SM
    [J]. DEVELOPMENTAL BIOLOGY, 1994, 161 (02) : 538 - 551
  • [14] TUMOR PREDISPOSITION IN MICE HETEROZYGOUS FOR A TARGETED MUTATION IN NF1
    JACKS, T
    SHIH, TS
    SCHMITT, EM
    BRONSON, RT
    BERNARDS, A
    WEINBERG, RA
    [J]. NATURE GENETICS, 1994, 7 (03) : 353 - 361
  • [15] LEDBETTER DH, 1989, AM J HUM GENET, V44, P20
  • [16] SOMATIC DELETION OF THE NEUROFIBROMATOSIS TYPE-1 GENE IN A NEUROFIBROSARCOMA SUPPORTS A TUMOR SUPPRESSOR GENE HYPOTHESIS
    LEGIUS, E
    MARCHUK, DA
    COLLINS, FS
    GLOVER, TW
    [J]. NATURE GENETICS, 1993, 3 (02) : 122 - 126
  • [17] LI Y, 1994, NNFF INT NF1 GENETIC
  • [18] CDNA CLONING OF THE TYPE-1 NEUROFIBROMATOSIS GENE - COMPLETE SEQUENCE OF THE NF1 GENE-PRODUCT
    MARCHUK, DA
    SAULINO, AM
    TAVAKKOL, R
    SWAROOP, M
    WALLACE, MR
    ANDERSEN, LB
    MITCHELL, AL
    GUTMANN, DH
    BOGUSKI, M
    COLLINS, FS
    [J]. GENOMICS, 1991, 11 (04) : 931 - 940
  • [19] THE GAP-RELATED DOMAIN OF THE NEUROFIBROMATOSIS TYPE-1 GENE-PRODUCT INTERACTS WITH RAS P21
    MARTIN, GA
    VISKOCHIL, D
    BOLLAG, G
    MCCABE, PC
    CROSIER, WJ
    HAUBRUCK, H
    CONROY, L
    CLARK, R
    OCONNELL, P
    CAWTHON, RM
    INNIS, MA
    MCCORMICK, F
    [J]. CELL, 1990, 63 (04) : 843 - 849
  • [20] NISHI T, 1991, ONCOGENE, V6, P1555